Edward Tenthoff
Stock Analyst at Piper Sandler
(2.24)
# 2,641
Out of 4,732 analysts
190
Total ratings
36.93%
Success rate
-1.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward Tenthoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Reiterates: Overweight | $78 | $32.66 | +138.82% | 4 | Dec 30, 2024 | |
| IPSC Century Therapeutics | Maintains: Overweight | $12 → $4 | $0.91 | +339.90% | 7 | Dec 30, 2024 | |
| MESO Mesoblast | Maintains: Overweight | $11 → $15 | $17.30 | -13.29% | 4 | Dec 19, 2024 | |
| XNCR Xencor | Upgrades: Overweight | $20 → $30 | $19.24 | +55.93% | 4 | Dec 2, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Overweight | $62 → $45 | $19.56 | +130.06% | 11 | Nov 27, 2024 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Overweight | $296 | $246.27 | +20.19% | 13 | Nov 18, 2024 | |
| MRNA Moderna | Reiterates: Overweight | $115 → $69 | $34.06 | +102.58% | 12 | Nov 18, 2024 | |
| OMGA Omega Therapeutics | Maintains: Overweight | $9 → $4 | $0.55 | +628.60% | 5 | Nov 15, 2024 | |
| KRON Kronos Bio | Downgrades: Neutral | $6 → $1 | $0.99 | +0.95% | 7 | Nov 14, 2024 | |
| TPST Tempest Therapeutics | Maintains: Overweight | $8 → $5 | $0.93 | +440.13% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $4.62 | +289.61% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $13.70 | +155.47% | 1 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $11 | $2.01 | +447.26% | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $53 | $14.13 | +275.09% | 5 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $20 | $2.66 | +651.88% | 3 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $3 | $1.47 | +104.08% | 6 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $13 → $5 | $0.22 | +2,178.94% | 6 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $3 | $1.31 | +129.01% | 4 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $5.66 | +182.94% | 3 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $40.53 | +159.07% | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $4 → $6 | $1.27 | +372.44% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 | $0.21 | +2,237.54% | 4 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $1.98 | +152.53% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $15 | $3.96 | +278.79% | 3 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $39 → $56 | $40.61 | +37.90% | 4 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $55 | $18.05 | +204.71% | 6 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $31 | $1.20 | +2,483.33% | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $3 | $0.51 | +491.02% | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $6 | $0.79 | +660.46% | 4 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $9 | $0.77 | +1,072.79% | 3 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $37 → $44 | $17.50 | +151.43% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $37 | $13.34 | +177.36% | 2 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $112,332 → $32,560 | $4.46 | +729,944.84% | 3 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $250 → $354 | $640.52 | -44.73% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $105 → $135 | $1.46 | +9,146.58% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $323 | $422.00 | -23.46% | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $36 | $36.20 | -0.55% | 2 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $50 → $25 | $2.46 | +916.26% | 2 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $0.57 | +26,078.01% | 1 | Jan 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $53 | $1.77 | +2,894.35% | 2 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,380 | $1.51 | +91,290.73% | 1 | Dec 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $681.58 | - | 11 | Feb 13, 2017 |
Legend Biotech
Dec 30, 2024
Reiterates: Overweight
Price Target: $78
Current: $32.66
Upside: +138.82%
Century Therapeutics
Dec 30, 2024
Maintains: Overweight
Price Target: $12 → $4
Current: $0.91
Upside: +339.90%
Mesoblast
Dec 19, 2024
Maintains: Overweight
Price Target: $11 → $15
Current: $17.30
Upside: -13.29%
Xencor
Dec 2, 2024
Upgrades: Overweight
Price Target: $20 → $30
Current: $19.24
Upside: +55.93%
Arrowhead Pharmaceuticals
Nov 27, 2024
Maintains: Overweight
Price Target: $62 → $45
Current: $19.56
Upside: +130.06%
Alnylam Pharmaceuticals
Nov 18, 2024
Reiterates: Overweight
Price Target: $296
Current: $246.27
Upside: +20.19%
Moderna
Nov 18, 2024
Reiterates: Overweight
Price Target: $115 → $69
Current: $34.06
Upside: +102.58%
Omega Therapeutics
Nov 15, 2024
Maintains: Overweight
Price Target: $9 → $4
Current: $0.55
Upside: +628.60%
Kronos Bio
Nov 14, 2024
Downgrades: Neutral
Price Target: $6 → $1
Current: $0.99
Upside: +0.95%
Tempest Therapeutics
Nov 13, 2024
Maintains: Overweight
Price Target: $8 → $5
Current: $0.93
Upside: +440.13%
Nov 5, 2024
Initiates: Overweight
Price Target: $18
Current: $4.62
Upside: +289.61%
Oct 21, 2024
Initiates: Overweight
Price Target: $35
Current: $13.70
Upside: +155.47%
Oct 11, 2024
Reiterates: Overweight
Price Target: $11
Current: $2.01
Upside: +447.26%
Sep 23, 2024
Reiterates: Overweight
Price Target: $53
Current: $14.13
Upside: +275.09%
Sep 20, 2024
Reiterates: Overweight
Price Target: $20
Current: $2.66
Upside: +651.88%
Sep 17, 2024
Reiterates: Overweight
Price Target: $3
Current: $1.47
Upside: +104.08%
Aug 13, 2024
Reiterates: Overweight
Price Target: $13 → $5
Current: $0.22
Upside: +2,178.94%
Jul 26, 2024
Maintains: Overweight
Price Target: $8 → $3
Current: $1.31
Upside: +129.01%
Jun 28, 2024
Reiterates: Overweight
Price Target: $16
Current: $5.66
Upside: +182.94%
Jun 17, 2024
Reiterates: Overweight
Price Target: $105
Current: $40.53
Upside: +159.07%
Jun 17, 2024
Upgrades: Overweight
Price Target: $4 → $6
Current: $1.27
Upside: +372.44%
Apr 3, 2024
Maintains: Overweight
Price Target: $5
Current: $0.21
Upside: +2,237.54%
Mar 5, 2024
Maintains: Overweight
Price Target: $6 → $5
Current: $1.98
Upside: +152.53%
Feb 28, 2024
Maintains: Overweight
Price Target: $13 → $15
Current: $3.96
Upside: +278.79%
Feb 27, 2024
Maintains: Overweight
Price Target: $39 → $56
Current: $40.61
Upside: +37.90%
Oct 23, 2023
Maintains: Overweight
Price Target: $70 → $55
Current: $18.05
Upside: +204.71%
Aug 14, 2023
Maintains: Overweight
Price Target: $28 → $31
Current: $1.20
Upside: +2,483.33%
Dec 12, 2022
Initiates: Overweight
Price Target: $3
Current: $0.51
Upside: +491.02%
Nov 4, 2022
Maintains: Overweight
Price Target: $13 → $6
Current: $0.79
Upside: +660.46%
Sep 7, 2022
Maintains: Overweight
Price Target: $7 → $9
Current: $0.77
Upside: +1,072.79%
Aug 25, 2022
Maintains: Overweight
Price Target: $37 → $44
Current: $17.50
Upside: +151.43%
May 23, 2022
Maintains: Overweight
Price Target: $76 → $37
Current: $13.34
Upside: +177.36%
May 13, 2022
Maintains: Overweight
Price Target: $112,332 → $32,560
Current: $4.46
Upside: +729,944.84%
Nov 29, 2021
Upgrades: Overweight
Price Target: $250 → $354
Current: $640.52
Upside: -44.73%
Sep 20, 2021
Maintains: Overweight
Price Target: $105 → $135
Current: $1.46
Upside: +9,146.58%
Jul 30, 2021
Maintains: Overweight
Price Target: $261 → $323
Current: $422.00
Upside: -23.46%
Feb 16, 2021
Maintains: Overweight
Price Target: $33 → $36
Current: $36.20
Upside: -0.55%
May 12, 2020
Downgrades: Neutral
Price Target: $50 → $25
Current: $2.46
Upside: +916.26%
Jan 27, 2020
Initiates: Overweight
Price Target: $150
Current: $0.57
Upside: +26,078.01%
Jan 6, 2020
Maintains: Overweight
Price Target: $26 → $53
Current: $1.77
Upside: +2,894.35%
Dec 11, 2017
Initiates: Overweight
Price Target: $1,380
Current: $1.51
Upside: +91,290.73%
Feb 13, 2017
Upgrades: Overweight
Price Target: n/a
Current: $681.58
Upside: -